Investing.com - AngioDynamics (NASDAQ: ANGO) reported second quarter EPS of $-0.04, $0.07 better than the analyst estimate of $-0.11. Revenue for the quarter came in at $73M versus the consensus estimate of $70.93M.
Guidance
AngioDynamics sees FY 2025 EPS of $-0.34 versus the analyst consensus of $-0.40.
AngioDynamics's stock price closed at $9.40. It is up 46.87% in the last 3 months and up 50.16% in the last 12 months.
AngioDynamics saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See AngioDynamics's stock price’s past reactions to earnings here.
According to InvestingPro, AngioDynamics's Financial Health score is "fair performance".
Check out AngioDynamics's recent earnings performance, and AngioDynamics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar